The Meakins-Christie Laboratories is one of the premier centres for pulmonary research in the world and Canada. The Meakins was founded in 1972 by Dr. Peter Macklem. It comprises the largest group of investigators within the Translational Research in Respiratory Diseases Program at the RI-MUHC. Our overall mission is to better understand the pathobiology of respiratory disorders. Our goal is to drive innovations in respiratory disease prevention, diagnosis, and therapy. As a result, our research is focused around five main themes: chronic airways disease, lung injury and infection, neuromuscular dysfunction in respiratory diseases, sleep-disordered breathing, and lung cancer.
In the News
Dr. Bill Powell’s preclinical research program on small molecule OXE receptor antagonists acquired by Liminal BioSciences
Dr. Basil Petrof will be a panelist on the ATS webinar “Clinical Aspects of COVID-19 Recovery”.